FDA Inspection 728992 — Nanjing White Whale Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanjing White Whale Pharmaceutical Co., Ltd. on June 10, 2011 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 10, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)